Seeking Alpha

BIND Therapeutics EPS of -$2.70, beats on revenues

  • BIND Therapeutics (BIND): Q3 EPS of -$2.70.
  • Revenue of $4.6M beats by $2.94M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: